Cargando…

Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic Review

BACKGROUND: People with advanced cancer experience psychological distress due to physical symptoms, functional decline, and a limited prognosis. Difficult thoughts, feelings, and emotions may exacerbate distress and lead to avoidance of these experiences which is sometimes referred to as experientia...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Sarah, Serfaty, Marc, Low, Joe, Armstrong, Megan, Kupeli, Nuriye, Lanceley, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522753/
https://www.ncbi.nlm.nih.gov/pubmed/36284042
http://dx.doi.org/10.1007/s12529-022-10131-4
_version_ 1785110421483552768
author Davis, Sarah
Serfaty, Marc
Low, Joe
Armstrong, Megan
Kupeli, Nuriye
Lanceley, Anne
author_facet Davis, Sarah
Serfaty, Marc
Low, Joe
Armstrong, Megan
Kupeli, Nuriye
Lanceley, Anne
author_sort Davis, Sarah
collection PubMed
description BACKGROUND: People with advanced cancer experience psychological distress due to physical symptoms, functional decline, and a limited prognosis. Difficult thoughts, feelings, and emotions may exacerbate distress and lead to avoidance of these experiences which is sometimes referred to as experiential avoidance (EA). Advanced cancer patients may be more likely to engage in EA especially when no obvious solutions to their problems exist. This study aims to examine the terms used to describe EA, the processes that might indicate EA, associations between EA and psychological distress, and to understand why individuals might engage in EA. METHODS: A mixed-methods review. Literature search of Medline, Embase, Psych INFO, and CINAHL 1980–October 2019. Inclusion: adults ≥ 18 years; advanced cancer not amenable to cure. Exclusion: no measures of EA or psychological distress. Risk of bias and study quality assessed. Evidence of statistical techniques collected. Themes coded, grouped, and developed based on meaning. RESULTS: Nineteen studies identified, 13 quantitative studies and 6 qualitative. The quantitative of which 6 compared early-stage cancers with advanced cancers and examined subscales of EA alongside mood, quality of life, and psychological distress. EA covers a range or terms of which ‘avoidant coping’ is the commonest. EA is manifest as cognitive, behavioural, and emotional avoidance. A thematic synthesis suggests the function of EA is to protect people from distress, and from confronting or expressing difficult emotions by avoiding communication about cancer, controlling negative information, and maintaining normality and hope and optimism. CONCLUSIONS: EA may be beneficial in the short term to alleviate distress, but in the longer term, it can impair function and limit engagement in life. Greater clinical awareness of the complexity of EA behaviours is needed. Clinicians and researchers should define EA precisely and be aware of the function it may serve in the short and longer term. Future research studies may consider using specific measures of EA as a primary outcome, to assess the impact of psychological interventions such as ACT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12529-022-10131-4.
format Online
Article
Text
id pubmed-10522753
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-105227532023-09-28 Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic Review Davis, Sarah Serfaty, Marc Low, Joe Armstrong, Megan Kupeli, Nuriye Lanceley, Anne Int J Behav Med Integrative Review BACKGROUND: People with advanced cancer experience psychological distress due to physical symptoms, functional decline, and a limited prognosis. Difficult thoughts, feelings, and emotions may exacerbate distress and lead to avoidance of these experiences which is sometimes referred to as experiential avoidance (EA). Advanced cancer patients may be more likely to engage in EA especially when no obvious solutions to their problems exist. This study aims to examine the terms used to describe EA, the processes that might indicate EA, associations between EA and psychological distress, and to understand why individuals might engage in EA. METHODS: A mixed-methods review. Literature search of Medline, Embase, Psych INFO, and CINAHL 1980–October 2019. Inclusion: adults ≥ 18 years; advanced cancer not amenable to cure. Exclusion: no measures of EA or psychological distress. Risk of bias and study quality assessed. Evidence of statistical techniques collected. Themes coded, grouped, and developed based on meaning. RESULTS: Nineteen studies identified, 13 quantitative studies and 6 qualitative. The quantitative of which 6 compared early-stage cancers with advanced cancers and examined subscales of EA alongside mood, quality of life, and psychological distress. EA covers a range or terms of which ‘avoidant coping’ is the commonest. EA is manifest as cognitive, behavioural, and emotional avoidance. A thematic synthesis suggests the function of EA is to protect people from distress, and from confronting or expressing difficult emotions by avoiding communication about cancer, controlling negative information, and maintaining normality and hope and optimism. CONCLUSIONS: EA may be beneficial in the short term to alleviate distress, but in the longer term, it can impair function and limit engagement in life. Greater clinical awareness of the complexity of EA behaviours is needed. Clinicians and researchers should define EA precisely and be aware of the function it may serve in the short and longer term. Future research studies may consider using specific measures of EA as a primary outcome, to assess the impact of psychological interventions such as ACT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12529-022-10131-4. Springer US 2022-10-25 2023 /pmc/articles/PMC10522753/ /pubmed/36284042 http://dx.doi.org/10.1007/s12529-022-10131-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Integrative Review
Davis, Sarah
Serfaty, Marc
Low, Joe
Armstrong, Megan
Kupeli, Nuriye
Lanceley, Anne
Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic Review
title Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic Review
title_full Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic Review
title_fullStr Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic Review
title_full_unstemmed Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic Review
title_short Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic Review
title_sort experiential avoidance in advanced cancer: a mixed-methods systematic review
topic Integrative Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522753/
https://www.ncbi.nlm.nih.gov/pubmed/36284042
http://dx.doi.org/10.1007/s12529-022-10131-4
work_keys_str_mv AT davissarah experientialavoidanceinadvancedcanceramixedmethodssystematicreview
AT serfatymarc experientialavoidanceinadvancedcanceramixedmethodssystematicreview
AT lowjoe experientialavoidanceinadvancedcanceramixedmethodssystematicreview
AT armstrongmegan experientialavoidanceinadvancedcanceramixedmethodssystematicreview
AT kupelinuriye experientialavoidanceinadvancedcanceramixedmethodssystematicreview
AT lanceleyanne experientialavoidanceinadvancedcanceramixedmethodssystematicreview